Cargando…

Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report

INTRODUCTION: Intravenous sedation and analgesia are widely used in minor surgeries. Remifentanil and remimazolam are advantageous in this setting because of their rapid onset of action, and short duration of action leading to a rapid recovery. However, the two drugs combined need to be titrated to...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Zhijun, Wang, Ning, Wang, Huaizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680086/
https://www.ncbi.nlm.nih.gov/pubmed/37198992
http://dx.doi.org/10.2174/1574886318666230517101142
_version_ 1785150660536172544
author Xin, Zhijun
Wang, Ning
Wang, Huaizhou
author_facet Xin, Zhijun
Wang, Ning
Wang, Huaizhou
author_sort Xin, Zhijun
collection PubMed
description INTRODUCTION: Intravenous sedation and analgesia are widely used in minor surgeries. Remifentanil and remimazolam are advantageous in this setting because of their rapid onset of action, and short duration of action leading to a rapid recovery. However, the two drugs combined need to be titrated to avoid airway-related adverse events. CASE PRESENTATION: This article reports a case of severe respiratory depression and severe laryngeal spasm induced by remifentanil and remimazolam when they were used for analgesia and sedation in a patient undergoing oral biopsy. CONCLUSION: We aim to improve awareness about the safety of these drugs among anesthesiologists and increase their ability to manage the risk associated with their use.
format Online
Article
Text
id pubmed-10680086
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-106800862023-11-27 Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report Xin, Zhijun Wang, Ning Wang, Huaizhou Curr Drug Saf Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology INTRODUCTION: Intravenous sedation and analgesia are widely used in minor surgeries. Remifentanil and remimazolam are advantageous in this setting because of their rapid onset of action, and short duration of action leading to a rapid recovery. However, the two drugs combined need to be titrated to avoid airway-related adverse events. CASE PRESENTATION: This article reports a case of severe respiratory depression and severe laryngeal spasm induced by remifentanil and remimazolam when they were used for analgesia and sedation in a patient undergoing oral biopsy. CONCLUSION: We aim to improve awareness about the safety of these drugs among anesthesiologists and increase their ability to manage the risk associated with their use. Bentham Science Publishers 2023-11-10 2023-11-10 /pmc/articles/PMC10680086/ /pubmed/37198992 http://dx.doi.org/10.2174/1574886318666230517101142 Text en © 2024 Bentham Science Publishers https://creativecommons.org/licenses/by/4.0/© 2024 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode)
spellingShingle Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology
Xin, Zhijun
Wang, Ning
Wang, Huaizhou
Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report
title Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report
title_full Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report
title_fullStr Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report
title_full_unstemmed Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report
title_short Remimazolam and Remifentanil Use Induced Severe Respiratory Depression and Laryngeal Spasm During Intravenous Sedation and Analgesia: A Case Report
title_sort remimazolam and remifentanil use induced severe respiratory depression and laryngeal spasm during intravenous sedation and analgesia: a case report
topic Drug Design, Discovery and Therapy, Drug Design & Discovery, Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680086/
https://www.ncbi.nlm.nih.gov/pubmed/37198992
http://dx.doi.org/10.2174/1574886318666230517101142
work_keys_str_mv AT xinzhijun remimazolamandremifentaniluseinducedsevererespiratorydepressionandlaryngealspasmduringintravenoussedationandanalgesiaacasereport
AT wangning remimazolamandremifentaniluseinducedsevererespiratorydepressionandlaryngealspasmduringintravenoussedationandanalgesiaacasereport
AT wanghuaizhou remimazolamandremifentaniluseinducedsevererespiratorydepressionandlaryngealspasmduringintravenoussedationandanalgesiaacasereport